Clarify Pharma PLC
| Symbol | Ccy Code | Bid | Ask | Share Price (Mid) | Previous Close | Volume | Last Traded |
|---|---|---|---|---|---|---|---|
| PSYC | GBX | 1 | 1.05 | 1.025 | 1.025 | 150000 | 09.11.22 |
MiFID II compliant pre- and post-trade transaction data is available here. The data is delayed by at least 15 minutes and will be refreshed every 15 minutes. Publication of trades in equity securities that are large in scale compared to normal market size and illiquid non-equity securities may be delayed if the trade is eligible for deferred publication in accordance with the trading rules of Aquis Stock Exchange and MiFIR. Further details as to when the publication of a trade may be deferred are set out in the trading rules which are available here.
Address
Business Address
Clarify Pharma PLC, 9th Floor, 16 Great Queen Street, London, WC2B 5DG, England.
Email: nl@nlconsulting.co.uk
Phone: +44 207 183 7407
Registered Address
9th Floor, 16 Great Queen Street, London, WC2B 5DG, England.
Contacts
Corporate Adviser
First Sentinel Corporate Finance, 72 Charlotte Street, London , United Kingdom.
Email: brian@first-sentinel.com
Phone: 020 3752 3118
Registrar
Computershare Investor Services PLC, The Pavilions, Bridgwater Road, Bristol, BS13 8AE, United Kingdom.
Email: web.queries@computershare.co.uk
Phone: 0370 703 6191
Research
There is no research available.